Guangwei Xu

2.9k citations
8 papers · 2.2k indexed · 1 hit paper · h-index 8
Topics
Hepatitis B Virus Studies (8 papers)Hepatitis C virus research (5 papers)Liver Disease Diagnosis and Treatment (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Guangwei Xu

8 papers receiving 2.2k citations

Hit Papers

Sodium taurocholate cotransporting polypeptide is a funct...2012202620162021201250010001.5k

Peers

Guangwei Xu
Comparison fields: 5 of 71
  • Epidemiology 2.0k
  • Hepatology 1.5k
  • Molecular Biology 373
  • Oncology 311
  • Infectious Diseases 291
Replace Zhenchao Gao with:
Zhenchao Gao China
Chen Pan China
B Ren China
G. Raffa Italy
Hans Christian Spangenberg Germany
Yasuhiro Itsui Japan
Patrick Soussan France
Anneke K. Raney United States
Hideharu Harada Japan
Vicky M.-H. Sung United States
Guangwei Xu relative to Zhenchao Gao China Zhenchao Gao's profile →
Citations per field
00.5×1.5×
Zhenchao Gao · 1×
Citations per year

Countries citing papers authored by Guangwei Xu

Since Specialization
Citations

This map shows the geographic impact of Guangwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangwei Xu more than expected).

Fields of papers citing papers by Guangwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangwei Xu. The network helps show where Guangwei Xu may publish in the future.

Co-authorship network of co-authors of Guangwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangwei Xu. A scholar is included among the top collaborators of Guangwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangwei Xu. Guangwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 17
2 39
3 158
4 191
5 153
6 15
7 55
8
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virusbreakdown →
1583

About Guangwei Xu

Guangwei Xu is a scholar working on Hepatology, Virology and Epidemiology, having authored 8 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (2.0k citations) and Virology (124 citations). Guangwei Xu has collaborated with scholars based in China and United States. Frequent co-authors include Wenhui Li, Wenhui He, Huan Yan, Zhiyi Jing, Xiaozhong Peng, Jianhua Sui, B Ren, Zhenchao Gao, Yonghe Qi and Mei Song. Their work appears in journals such as Journal of Virology, PLoS Pathogens and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026